title: [The angiographic classification and sclerotherapy of cavernous hemangiomas of maxilloface].
abstract: OBJECTIVE
  To explore the factors that affect the curative effect and the best method of treatment for the patients with maxillofacial cavernous hemangiomas.
  
  
  METHODS
  102 cases of maxillofacial cavernous hemangiomas were performed DSA examination and taken serial photography. According to the diameter, number and draining speed of efferent veins of the tumor, the cavernous hemangiomas were classified into two types-the high efferent speed and low efferent speed type. For all of them, were randomly performed embolization of efferent veins with absolute ethanol plus bleomycin-A5 intratumor injection (group I) and bleomycin-A5 intratumor injection alone (group II).
  
  
  RESULTS
  The cure rate and general effective rate has significant difference (P < 0.01) between two groups in 70 patients with high efferent speed veins, while no significant difference (P > 0.05) in 32 patients with low efferent speed veins.
  
  
  CONCLUSIONS
  This new classification is beneficial for seeking method of treatment. The embolization of efferent veins is an effective method for cavernous hemangioma with high efferent speed veins; but for the type with low efferent speed veins, bleomycin-A5 intratumor injection alone could acquire a good results.
authors.affiliation: Department of Hemangioma, Cancer Hospital of Shandong Linyi, Linyi Shandong 276001, China.
authors.forename: Zhongping
authors.initials: Z
authors.lastname: Qin
authors.forename: Kelei
authors.initials: K
authors.lastname: Li
authors.forename: Xuejian
authors.initials: X
authors.lastname: Liu
authors.forename: Xueji
authors.initials: X
authors.lastname: Li
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D004621:Embolization, Therapeutic; D005153:Facial Neoplasms / Q000145:classification / Q000000981:diagnostic imaging / Q000628:therapy*; D005260:Female; D006392:Hemangioma, Cavernous / Q000145:classification / Q000000981:diagnostic imaging / Q000628:therapy*; D006801:Humans; D008297:Male; D008441:Maxillary Neoplasms / Q000145:classification / Q000000981:diagnostic imaging / Q000628:therapy*; D008875:Middle Aged; D011859:Radiography; D015911:Sclerotherapy